Clinical Trial Update: AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 results update for AST-VAC2 vaccine in patients with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AST-VAC2 vaccine (AST-VAC2)

Snippet

Sponsor: Cancer Research UK | Conditions: Advanced Non-small Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-08-09